Skip to main content

Oculis Holding AG

corporate_fare Company Profile

Oculis Holding AG

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed OCS - Latest Insights

OCS
Apr 21, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
8
Oculis Seeks Shareholder Approval for Substantial Capital Authorization and Reports Positive Clinical Progress
Sentiment: Neutral
View Wiseek Article
OCS
Mar 31, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
EMA Grants PRIME Designation to Oculis' Privosegtor, Accelerating First-in-Class Optic Neuritis Treatment
Sentiment: Positive
View Wiseek Article
OCS
Mar 04, 2026, 4:31 PM EST
Filing Type: 6-K
Importance Score:
7
Oculis Renews $100M At-The-Market Offering Program; Final Earnout Target Met
Sentiment: Neutral
View Wiseek Article
OCS
Mar 04, 2026, 4:19 PM EST
Filing Type: F-3ASR
Importance Score:
7
Oculis Files F-3ASR for $100M At-The-Market Offering Program Renewal
Sentiment: Neutral
View Wiseek Article
OCS
Mar 04, 2026, 4:01 PM EST
Filing Type: 20-F
Importance Score:
8
Oculis Reports Strong Cash Position and Advances Multiple Drug Candidates into Registrational Trials
Sentiment: Positive
View Wiseek Article
OCS
Mar 03, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
9
Oculis' Privosegtor Earns FDA Breakthrough Therapy, Cash Runway Extends to 2029
Sentiment: Positive
View Wiseek Article